Portable Patient Transport System (PPTS) Final

The U.S. Army Contracting Command-Aberdeen Proving Ground seeks proposals for a Portable Patient Transport System (PPTS) to safely transport infectious, non-ambulatory patients by various means, including air, ground, rail, or sea. The

The provided document outlines technical requirements for a Force Protection system, likely part of a federal government Request for Proposal (RFP) or Call for Solutions (CFS). It details six critical functional requirements: maintaining a negative pressure differential of at least 0.01 inches of water gauge, directing airflow from the patient's head to foot, providing at least 12 air exchanges per hour, achieving exhaust air filtration of at least 99.97% for 0.3-micron particles, ensuring filters meet or exceed NIOSH HE certified standards, and containing at least 3 liters of liquid contamination without leaking. Offerors are instructed to complete an Assertion Matrix within a 15-page Solution Brief, asserting compliance (Met, Partially Met, Not Met, Exceeds) for each requirement and providing verifiable evidence in a

The U.S. Army Contracting Command-Aberdeen Proving Ground (ACC-APG) has issued a Call for Solutions (CFS) for a Portable Patient Transport System (PPTS). This system is intended for the safe containment and transport of single, non-ambulatory infectious patients by air, rail, ground, or sea, addressing an urgent need for the Department of War. The CFS, numbered W911QY-26-S-PPTS-01, seeks innovative solutions for the Biocontainment, Isolation, and Quarantine (BIQ) PPTS program. Key objectives include airworthiness certification, robust bio-containment, long-duration patient sustainment, and FDA marketing authorization. Offerors must submit a Solution Brief and Supporting Data Package by June 3, 2026. The evaluation process is multi-phased, starting with Solution Briefs assessed against minimum threshold requirements in Table 1, followed by a Request for Solution Proposal (RSP) for selected offerors. The government intends to award multiple Prototype Other Transaction (OT) Agreements, with a strong preference for unlimited data rights. AI tools may be used for proposal evaluation, but final decisions remain with government personnel. The project culminates in a potential non-competitive follow-on production award for up to 476 units over four years upon successful completion of the prototype project, which requires meeting specified technical goals and criteria.

The document addresses numerous questions regarding the Portable Patient Transport System (PPTS) within the context of federal government RFPs, specifically focusing on its design, interoperability, compliance, and procurement. Key areas of inquiry include interoperability requirements between BIQ programs, Berry amendment compliance, disinfection processes, funding for projects, partnering preferences, and the preference for system or components. The document also delves into technical specifications such as weight limits, glove port design, temperature ranges, and filter requirements. Procurement details, including the use of the CWMD OTA, clarification on "significant participant" under AOS, and the timeline for CFS posting and question submissions, are also covered. The government's responses clarify many of these points, emphasizing compliance with MIL-STD-1472, ASTM F1671, and ASTM D6319, and the preference for solutions compatible with NATO litter. It also outlines the FDA marketing authorization and airworthiness certification process, the role of government support, and the consideration of alternative designs and waste management approaches, while stressing the importance of affordability across all phases.

The document, marked for "DoW COMMUNITY ONLY" distribution, comprises a Q&A log concerning the Portable Patient Transport System (PPTS). It addresses various technical and compliance aspects of the PPTS, focusing on design specifications, operational requirements, and regulatory adherence. Key topics include the dimensions and rationale behind glove port placement (33-43 cm center-to-center distance for 14 total ports arranged in pairs), distinctions between transport pouches (for items up to 8x12 inches) and pass-through ports (for cabling and patient care devices), and filtration requirements (outside the enclosure, HEPA-equivalent, NIOSH P-100 threshold). The document also clarifies Berry Amendment compliance, emphasizing its statutory nature and the government's strong preference for compliant prototypes. Data rights are a significant concern, with a strong preference for Unlimited Rights and negative evaluation for proposals offering less than Government Purpose Rights. The government indicates willingness to consider alternative interface designs for pass-through functionality and bilateral access if operational effectiveness is demonstrated. Affordability will be considered at all phases of the OTA. The document also touches upon FDA clearance paths and intellectual property assertions, emphasizing a credible approach to meeting project objectives.

The U.S. Army Contracting Command-Aberdeen Proving Ground (ACC-APG), Natick Contracting Division (NCD), issued a Call for Solutions (CFS) for a Portable Patient Transport System (PPTS) under the authority of 10 U.S.C. § 4022. This CFS seeks a man-portable system to control biological threats during the transport of a single, non-ambulatory infectious patient by various means (air, rail, ground, or sea). The system must be flight-certified, ambulance-compatible, and operable in austere environments, protecting the force, platform, and crew while allowing high-standard medical care. The acquisition strategy is multi-phased, focusing on airworthiness, biocontainment, patient sustainment, and FDA marketing authorization. Offerors must submit a Solution Brief and a Supporting Data Package by June 3, 2026, meeting minimum threshold requirements in areas like negative pressure differential, air flow, filtration, and liquid containment. Submissions will be evaluated on technical merit, innovation, IP strategy, and affordability. Selected offerors will be invited to submit a full Request for Solution Proposal (RSP), with subsequent down-selections through Segment I and Segment II phases. The government prefers unlimited rights for all technical data and intellectual property. Successful completion criteria are outlined for potential non-competitive follow-on production awards of up to 476 units.

The Statement of Objectives (SOO) outlines the U.S. Government's requirement for a Portable Patient Transport System (PPTS) to safely transport single, non-ambulatory infectious patients by air, rail, ground, or sea. The system must prevent the spread of biological threats through a containment enclosure with an integrated, battery-powered negative pressure air filtration system, including features like glove ports, pass-through interfaces, and windows for patient care. The acquisition is a multi-phased prototype project under 10 U.S.C. § 4022, with Segment I involving initial delivery and evaluation of 30 prototypes, and Segment II focusing on advanced integration, environmental testing, airworthiness, and operational flight testing, culminating in FDA marketing authorization and airworthiness certification. Successful prototypes may lead to a non-competitive follow-on production award for up to 476 units. Proposals must include a draft Statement of Work, regulatory strategy, delivery schedule, cost details, and data rights assertions, with a strong preference for unlimited government data rights.

The U.S. Army Contracting Command-Aberdeen Proving Ground (ACC-APG), Natick Contracting Division (NCD), has issued a Call for Solutions (CFS) for a Portable Patient Transport System (PPTS). This CFS, W911QY-26-S-PPTS-01, seeks a man-portable system for safe, contained intra- and inter-theater transport of single, non-ambulatory infectious patients by various means (air, rail, ground, sea). The system must prevent biothreat spread, protect personnel, and allow high-standard medical care. Key objectives include airworthiness certification, robust biocontainment, long-duration patient sustainment, and FDA 510(k) clearance. Offerors must submit a

The Statement of Objectives (SOO) outlines the development and acquisition of a Portable Patient Transport System (PPTS) for transporting single, non-ambulatory infectious patients while preventing biological threat spread. This multi-phased prototype project, authorized under 10 U.S.C. § 4022, seeks a man-portable system with an integrated, battery-powered air filtration system to create negative pressure and filter exhaust air. Key features include glove ports, pass-through interfaces, and patient visibility. The program involves two segments: Segment I (Phase I) for initial prototypes and Segment II (Phases II and III) for advanced integration, certification, and airworthiness testing. Successful prototypes must meet stringent criteria for leak containment, force protection, air changes, filtration efficiency, power, FDA 510(k) clearance, patient interfaces, patient care, and compatibility with various transport modes. The SOO details proposal submission requirements, emphasizing novel concepts, cost, production rates, and data rights. Deliverables include prototype systems and comprehensive documentation for each phase, with a potential for a non-competitive follow-on production award of up to 400 units.

The JPM CBRN Protection Industry Day outlines a schedule for two groups of companies presenting on Biological Containment Isolation System (BCIS), Portable Patient Transport System (PPTS), and Shipboard Isolation System (SIS). Group 1 features eleven companies, including P2 Mission Solutions, JGW Group Peke Safety LLC, Safe Decon Inc, Knight Aerospace, HDT Global, Valinor, LifePort, LLC, ISOVAC Products, Inspire Rx LLC, EpiGuard AS, and Battelle. Group 2 lists five companies: GUILD ASSOCIATES INC, Stitch Partners LLC, Duke Human Vaccine Institute, Air, Univox LLC, and Carecubes Inc. The schedule indicates specific time slots for each company's presentation, with several slots in Group 2 remaining unassigned. This event appears to be a forum for industry leaders to showcase solutions related to biological containment and patient transport systems, likely in response to a government request for information or a precursor to a future RFP in CBRN protection.

This document addresses numerous questions regarding a government Request for Proposal (RFP) for Portable Patient Transport Systems (PPTS) and other related systems. Key topics covered include system specifications, such as the need for monitors, distance between glove ports, rationale for port numbers, and the difference between transport pouches and pass-through ports. The government clarifies its willingness to consider alternative designs for glove ports and interface designs, and outlines the types of large items intended for transfer. Intellectual property and data rights, specifically the government's preference for unlimited rights, are discussed, along with Berry Amendment compliance for prototypes. Regulatory requirements, particularly FDA clearance, are a significant focus, with the government outlining its anticipated timeline, potential support for performers, and considering credible Phase III paths to clearance. Filter requirements, including HEPA-equivalent filtration performance and the preference for external filters, are detailed. The document also touches on funding, interoperability, litter compatibility, flame resistance, glove types, caregiver protection, and crucial logistical information like quantities, deadlines, and weight limits for man-portability. Waste management approaches and the anticipated lifespan of the systems are also addressed. The government emphasizes considering alternative solutions that meet the spirit of the requirements, even if they deviate from specific initial preferences.